Marco Mazzocchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marco Mazzocchi has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Benedetta Mascia
Foundation Polyclinic San Matteo, I.R.C.C.S. (Scientific Institute for Research, Hospitalization and Health Care), Pavia, Italy
2 shared publications - Maria Giuseppina Onesti
Sapienza University of Rome
2 shared publications Nicolò Scuderi
“La Sapienza” University of Rome
2 shared publicationsA Colombo
Foundation Polyclinic San Matteo, I.R.C.C.S. (Scientific Institute for Research, Hospitalization and Health Care), Pavia, Italy
1 shared publication- Alessandra Stella
Istituto di Biologia e Biotecnologia Agraria, Consiglio Nazionale delle Ricerche (CNR), 20133 Milan, Italy
1 shared publication - Antonio V. Pellegrini
UO CRIO, IRCCS Ospedale Galeazzi‐Sant'Ambrogio Milano Italy
1 shared publication
Latest Publications
- Open Access
- 9 September 2021
- Published by BMJ
- Vol. 70 (Suppl 1) , A40.3-A41
77 Serratus anterior plane block (SAPB) for the treatment of resistant Herpes Zoster thoracic pain and neuralgia: deafferentation as an optimal chance for pain relief
Background and Aims Herpes Zoster reactivation causes inflammatory and hemorrhagic reaction in the posterior roots of spinal nerves and sensitive ganglia. Postherpetic neuralgia (PHN)1 is a neuropathic pain that occurs in 25% of patients older than 502,3. Pharmacological therapy is often uneffective; intrathecal steroid injections and nerve blocks may be tried4. Serratus anterior plane block (SAPB)5 could provide effective analgesia. Methods We treated 2 female patients with PHN, unresponsive to medical therapies, 56 and 74 yo; pain was localized in the antero-lateral area of thorax, limiting free movements of ipsilateral arm. Pain was strong (NRS score 8 and 10), stabbing and burning, exacerbating in absence of stimuli and without relief during the night. We performed an ultrasound-guided SAPB with 0.25%-levobupivacaine 30 ml and dexamethasone 8 mg at 5th intercostal space. Results Both patients had immediate pain relief: NRS was 2–3 after 10 minutes, 0–1 after 2 hours. Benefit was substantially maintained over time: at 48 hours, resumption of pain was mild (NRS 2) in the first patient, moderate (NRS 4–5) in the second; in this patient we decided to perform another injection. NRS finally decreased to 2–3 and there was no need for further injections. At two months there was absence of pain for both. Conclusions Long-lasting SAPB with local anesthetic and steroids could be a safe and effective way to treat resistant PHN, and it should be performed as soon as possible to avoid incipit of chronic pain and improve patient quality of life and outcome. Further studies are necessary to confirm our preliminary data.
- 9 September 2021
- Published by BMJ
- Vol. 70 (Suppl 1) , A40.3-A41
Open Access77 Serratus anterior plane block (SAPB) for the treatment of resistant Herpes Zoster thoracic pain and neuralgia: deafferentation as an optimal chance for pain relief
Background and Aims Herpes Zoster reactivation causes inflammatory and hemorrhagic reaction in the posterior roots of spinal nerves and sensitive ganglia. Postherpetic neuralgia (PHN)1 is a neuropathic pain that occurs in 25% of patients older than 502,3. Pharmacological therapy is often uneffective; intrathecal steroid injections and nerve blocks may be tried4. Serratus anterior plane block (SAPB)5 could provide effective analgesia. Methods We treated 2 female patients with PHN, unresponsive to medical therapies, 56 and 74 yo; pain was localized in the antero-lateral area of thorax, limiting free movements of ipsilateral arm. Pain was strong (NRS score 8 and 10), stabbing and burning, exacerbating in absence of stimuli and without relief during the night. We performed an ultrasound-guided SAPB with 0.25%-levobupivacaine 30 ml and dexamethasone 8 mg at 5th intercostal space. Results Both patients had immediate pain relief: NRS was 2–3 after 10 minutes, 0–1 after 2 hours. Benefit was substantially maintained over time: at 48 hours, resumption of pain was mild (NRS 2) in the first patient, moderate (NRS 4–5) in the second; in this patient we decided to perform another injection. NRS finally decreased to 2–3 and there was no need for further injections. At two months there was absence of pain for both. Conclusions Long-lasting SAPB with local anesthetic and steroids could be a safe and effective way to treat resistant PHN, and it should be performed as soon as possible to avoid incipit of chronic pain and improve patient quality of life and outcome. Further studies are necessary to confirm our preliminary data.
- Open Access
- 9 September 2021
- Published by BMJ
- Vol. 70 (Suppl 1) , A45-A46
86 Serratus anterior plane block (SAPB) in severe chest trauma with multiple rib fractures (MRF): Optimal combination between analgesia and improved lung function?
Background and Aims 10% of polytraumatized patients have multiple rib fractures. Associated severe pain can lead to hypoventilation and respiratory complications in 31% of cases1. ‘Opioid-sparing analgesia’ as epidural and multimodal analgesia are recommended2. We hypotize that SAPB3,4 can provide effective, safe and long-lasting analgesia (thanks to dexamethasone added to local anaesthetic) and reduce respiratory complications, enhancing recovery of a better mechanical lung function. Methods 15 patients(age 64±15) hospitalized for polytrauma with MRF(8±4) and severe pain(NRS> 4), impairing maximal inspiration and coughing, were treated with multimodal analgesia + SAPB(ethical committee approval obtained). We injected levobupivacaine 0.25% 30 ml and dexamethasone (8 mg) within the myofascial plane of serratus anterior. We registered respiratory rate(RR), heart rate(HR) and NRS at rest(NRSrest), during maximal inspiration(NRSdeep) and coughing(NRScough) before SAPB(T0), after 15 minutes(T1) and after 4 hours(T2). At T0 and T2, lung ultrasound(LUS) and diaphragmatic ultrasound(DUS) were performed. Incidence of opioid-related side effects and respiratory complications were recorded. Results We observed a significant reduction in NRSrest, NRSdeep, NRScough, HR and RR at both T1 and T2 in all patients. LUS revealed a significant improvement in lung aeration, DUS showed a significant increase in diaphragm excursion. Duration of analgesia was greater than 30 hours in most patients, greater than 48 hours in almost 50%. No patient asked for rescue-analgesia. No patient had respiratory complications. Conclusions Both clinical and instrumental data suggest that SAPB is safe and provides effective opioid-sparing analgesia. Pain reduction allows improvement in pulmonary aeration and diaphragmatic function, suggesting a possible role in prevention of pulmonary complications.
- 9 September 2021
- Published by BMJ
- Vol. 70 (Suppl 1) , A45-A46
Open Access86 Serratus anterior plane block (SAPB) in severe chest trauma with multiple rib fractures (MRF): Optimal combination between analgesia and improved lung function?
Background and Aims 10% of polytraumatized patients have multiple rib fractures. Associated severe pain can lead to hypoventilation and respiratory complications in 31% of cases1. ‘Opioid-sparing analgesia’ as epidural and multimodal analgesia are recommended2. We hypotize that SAPB3,4 can provide effective, safe and long-lasting analgesia (thanks to dexamethasone added to local anaesthetic) and reduce respiratory complications, enhancing recovery of a better mechanical lung function. Methods 15 patients(age 64±15) hospitalized for polytrauma with MRF(8±4) and severe pain(NRS> 4), impairing maximal inspiration and coughing, were treated with multimodal analgesia + SAPB(ethical committee approval obtained). We injected levobupivacaine 0.25% 30 ml and dexamethasone (8 mg) within the myofascial plane of serratus anterior. We registered respiratory rate(RR), heart rate(HR) and NRS at rest(NRSrest), during maximal inspiration(NRSdeep) and coughing(NRScough) before SAPB(T0), after 15 minutes(T1) and after 4 hours(T2). At T0 and T2, lung ultrasound(LUS) and diaphragmatic ultrasound(DUS) were performed. Incidence of opioid-related side effects and respiratory complications were recorded. Results We observed a significant reduction in NRSrest, NRSdeep, NRScough, HR and RR at both T1 and T2 in all patients. LUS revealed a significant improvement in lung aeration, DUS showed a significant increase in diaphragm excursion. Duration of analgesia was greater than 30 hours in most patients, greater than 48 hours in almost 50%. No patient asked for rescue-analgesia. No patient had respiratory complications. Conclusions Both clinical and instrumental data suggest that SAPB is safe and provides effective opioid-sparing analgesia. Pain reduction allows improvement in pulmonary aeration and diaphragmatic function, suggesting a possible role in prevention of pulmonary complications.
- 16 November 2010
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 35 (3) , 373-381
Phase 2 Cross-Over Multicenter Trial on the Efficacy and Safety of Topical Cyanoacrylates Compared with Topical Silicone Gel in the Prevention of Pathologic Scars
Many clinical studies on scar therapy are reported in the literature, but only silicone gel sheeting and corticosteroid injections are supported by accurate prospective controlled studies. This prospective multicenter cross-over phase 2 study tested the effectiveness of a topical cyanoacrylate compared with silicone gel in improving postsurgical scars Patients presenting with symmetric breast scars after augmentation or reduction mammaplasty were enrolled in the study. From the same day as stitch removal, the cyanoacrylate was applied on one side every 3 to 5 days and the silicone gel on the other side twice a day for 3 months. Assessments of patients and external observers using a visual analog scale were recorded at scheduled visits during 1 year, and scars were photographed. Objective evaluations included measurements of scar width, length, and elevation. The statistical significance of objective parameter modifications was analyzed using the Wilcoxon test Positive effects of both tested products were observed during the scar maturation process, and final scars of good quality were achieved without any major adverse effect. The topical cyanoacrylate proved to be more efficacious in preventing scar widening, and this result was statistically significant The tested topical cyanoacrylate had a positive effect on the scar maturation process at least comparable with that of topical silicone gel.
- 16 November 2010
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 35 (3) , 373-381
Phase 2 Cross-Over Multicenter Trial on the Efficacy and Safety of Topical Cyanoacrylates Compared with Topical Silicone Gel in the Prevention of Pathologic Scars
Many clinical studies on scar therapy are reported in the literature, but only silicone gel sheeting and corticosteroid injections are supported by accurate prospective controlled studies. This prospective multicenter cross-over phase 2 study tested the effectiveness of a topical cyanoacrylate compared with silicone gel in improving postsurgical scars Patients presenting with symmetric breast scars after augmentation or reduction mammaplasty were enrolled in the study. From the same day as stitch removal, the cyanoacrylate was applied on one side every 3 to 5 days and the silicone gel on the other side twice a day for 3 months. Assessments of patients and external observers using a visual analog scale were recorded at scheduled visits during 1 year, and scars were photographed. Objective evaluations included measurements of scar width, length, and elevation. The statistical significance of objective parameter modifications was analyzed using the Wilcoxon test Positive effects of both tested products were observed during the scar maturation process, and final scars of good quality were achieved without any major adverse effect. The topical cyanoacrylate proved to be more efficacious in preventing scar widening, and this result was statistically significant The tested topical cyanoacrylate had a positive effect on the scar maturation process at least comparable with that of topical silicone gel.
- 18 December 2008
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 33 (3) , 452-456
Minimally Invasive Combined Treatment for Parry-Romberg Syndrome
Facial hemiatrophy, a typical manifestation of Parry-Romberg syndrome, produces massive face asymmetry, causing marked aesthetic damage and severe psychological discomfort, with repercussions to the psychophysical status of the patient. This article presents a successful combined treatment that results in resolution of symptoms and patient satisfaction. The authors proposed a clinic-therapeutic management comprising a customized program of bio-lipo-intense pulsed light (IPL) remodeling. In 2007, at a 1-year follow-up visit, the patient presented a stable result. She is satisfied with the augmentation treatment, the new volume and contours of the face, and the resolution of the sclerosis and ochrodermia. The authors have succeeded with a minimally invasive reconstructive technique for Romberg disease using a customized therapeutic program of poly-L-lactic acid, lipofilling, and IPL therapy. They report a case of good healing without recurrences and complications, with a good cosmetic result, and with satisfaction of the patient.
- 18 December 2008
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 33 (3) , 452-456
Minimally Invasive Combined Treatment for Parry-Romberg Syndrome
Facial hemiatrophy, a typical manifestation of Parry-Romberg syndrome, produces massive face asymmetry, causing marked aesthetic damage and severe psychological discomfort, with repercussions to the psychophysical status of the patient. This article presents a successful combined treatment that results in resolution of symptoms and patient satisfaction. The authors proposed a clinic-therapeutic management comprising a customized program of bio-lipo-intense pulsed light (IPL) remodeling. In 2007, at a 1-year follow-up visit, the patient presented a stable result. She is satisfied with the augmentation treatment, the new volume and contours of the face, and the resolution of the sclerosis and ochrodermia. The authors have succeeded with a minimally invasive reconstructive technique for Romberg disease using a customized therapeutic program of poly-L-lactic acid, lipofilling, and IPL therapy. They report a case of good healing without recurrences and complications, with a good cosmetic result, and with satisfaction of the patient.